Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) EBT Margin (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 6 years of EBT Margin data on record, last reported at 114.97% in Q3 2025.

  • For Q3 2025, EBT Margin rose 46647.0% year-over-year to 114.97%; the TTM value through Sep 2025 reached 127.25%, up 292687.0%, while the annual FY2024 figure was 181.4%, N/A changed from the prior year.
  • EBT Margin reached 114.97% in Q3 2025 per CYCN's latest filing, up from 1797.85% in the prior quarter.
  • Across five years, EBT Margin topped out at 627.5% in Q3 2022 and bottomed at 21604.84% in Q1 2021.
  • Average EBT Margin over 4 years is 3161.68%, with a median of 1798.31% recorded in 2025.
  • Peak YoY movement for EBT Margin: tumbled -1960997bps in 2021, then skyrocketed 1977868bps in 2022.
  • A 4-year view of EBT Margin shows it stood at 2690.24% in 2021, then soared by 123bps to 627.5% in 2022, then crashed by -96bps to 27.8% in 2024, then plummeted by -514bps to 114.97% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 114.97% in Q3 2025, 1797.85% in Q2 2025, and 1798.77% in Q1 2025.